94 Chapter 3 References 1. European Commission, Directorate-General for Research and Innovation, Group of Chief Scientific Advisors. Cancer screening in the European Union 2022. 2. European Colorectal Cancer Screening Guidelines Working G, von Karsa L, Patnick J, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication. Endoscopy 2013;45(1):51-9. 3. Zielonke N, Gini A, Jansen EE, Anttila A, et al. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review. Eur J Cancer 2020;127:191-206. 4. van Ballegooijen M, van den Akker-van Marle E, Patnick J, Lynge E, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;36(17):2177-88. 5. Rijksinstituut voor Volksgezondheid en Milieu. Population screening programmes, 2022. Available via: https://www.rivm.nl/node/99391. Accessed May 2022. 6. Rijksinstituut voor Volksgezondheid en Milieu. The National Breast Cancer Screening Programme, 2022. Available via: https://www.rivm.nl/en/breast-cancer-screeningprogramme. Accessed May 2022. 7. Rijksinstituut voor Volksgezondheid en Milieu. The National Colorectal Cancer Screening Programme, 2022. Available via: https://www.rivm.nl/en/colorectal-cancer-screeningprogramme. Accessed May 2022. 8. Young B, Robb KA. Understanding patient factors to increase uptake of cancer screening: a review. Future Oncol 2021;17(28):3757-75. 9. Lynge E, Törnberg S, von Karsa L, Segnan N, et al. Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer 2012;48(5):743-8. 10. World Health Organization. Cancer control: Early detection. WHO guide for effective programmes 2007. 11. World Health Organization. National cancer control programmes: policies and managerial guidelines: World Health Organization 2002. 12. World Health Organization. Guide to cancer early diagnosis 2017. 13. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Borstkanker 2020. Available via: https://www.rivm.nl/bevolkingsonderzoek-borstkanker/ professionals/monitoring-en-evaluatie. Accessed May 2022. 14. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Darmkanker 2020. Available via: https://www.rivm.nl/bevolkingsonderzoek-darmkanker/ professionals/monitoring-en-evaluatie. Accessed May 2022. 15. Stichting Bevolkingsonderzoek Nederland. Jaarbericht 2020. Available via: https://www. jaarberichtbevolkingsonderzoeknederland2020.nl/. Accessed May 2022. 16. Bongaerts THG, Büchner FL, Middelkoop BJ, Guicherit OR, et al. Determinants of (non-) attendance at the Dutch cancer screening programmes: A systematic review. J Med Screen 2020;27(3):121-9. 17. Bevolkingsonderzoek Zuid-West. Jaarverslag 2019. Available via: https://www. bevolkingsonderzoeknederland.nl/media/1442/jaarverslag-2019_def.pdf. Accessed January 2021. 18. Netherlands Comprehensive Cancer Organisation. IKNL and the NCR, 2020. Available via: https://iknl.nl/en. Accessed May 2022.
RkJQdWJsaXNoZXIy MTk4NDMw